Filing Flows › Enanta Pharmaceuticals (ENTA) › Recalls, complaints & regulation
Enanta Pharmaceuticals (ENTA): clinical trials
Enanta Pharmaceuticals (ENTA) beyond its filings: 3 active clinical trials.
Enanta Pharmaceuticals' latest quarter
Enanta Pharmaceuticals, Q3 FY26: revenue $14.4M (-22% year over year), operating margin -120.0%, net loss $19.5M, operating cash flow −$10.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Enanta Pharmaceuticals have?
3 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.